Hudson Bay Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Hudson Bay Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30,000	Closed	-$1.26M	–	911
2017 Q4	$1.26M	Buy	+30,000	New	+$1.16M	0.03%	371
2017 Q3	–	Sell	-210,000	Closed	-$2.75M	–	582
2017 Q2	$2.75M	Buy	210,000 +157,516	+300%	+$2.08M	0.06%	292
2017 Q1	$690K	Buy	+52,484	New	+$672K	0.01%	675

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Hudson Bay Capital Management's MYOK Position: Q1 2018 in Review

Hudson Bay Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2018, closing a stake of 30,000 shares — an estimated $1.26M sold.

Hudson Bay Capital Management first reported a position in MYOK in Q1 2017 and held it in 3 quarters. The position peaked at $2.75M in Q2 2017. 128 funds tracked by Wall St. Rank hold MYOK as of Q1 2018.

Hudson Bay Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Hudson Bay Capital Management sold 30,000 MyoKardia, Inc. Common Stock shares in Q1 2018, an estimated $1.26M.
Hudson Bay Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
Hudson Bay Capital Management's MyoKardia, Inc. Common Stock position peaked at $2.75M in Q2 2017.
128 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2018.

Based on Hudson Bay Capital Management's 13F filing for Q1 2018, filed 14 May 2018.